Skip to content

PTHS PTHS Amended Sato license — Less: current portion

Similar metrics at other companies

Syndax Pharmaceuticals logo
SNDXCapital Lease Less Current Portion
$907K-37.6%
McEwen Mining logo
MUXLease Liability Non Current
$933K-22.4%
Perpetua Resources Corp. logo
PPTALease Liability Non Current
$2.75M
Array Technologies, Inc. logo
ARRYLease liabilities, net of current portion
$89.2M
Everspin Technologies logo
MRAMTotal lease liabilities, net of current portion
$1.6M-46.7%
ATN International logo
ATNILease Liability Noncurrent
$70.94M-4.0%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept pths:ContractualObligationCurrent.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's amended sato license — less: current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's amended sato license — less: current portion?
PTHS (PTHS) reported amended sato license — less: current portion of $116K in Q1 2026.
What does amended sato license — less: current portion mean?
This represents the long-term portion of the liability associated with the amended Sato licensing agreement, excluding amounts due within the next twelve months. It reflects the non-current financial obligation arising from the acquisition or licensing of intellectual property rights. Investors use this to assess the company's long-term debt maturity profile related to specific technology assets.